Randomized, double-blind, placebo-controlled, multiple-dose study of the safety, tolerability and pharmacokinetics of benvitimod, a candidate drug for the treatment of psoriasis
2014 ◽
Vol 39
(4)
◽
pp. 418-423
◽
Keyword(s):